Geron Corporation (GERN)

6.38 +0.18 (+2.903%)

IEX Real-Time Price

September 25, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 6.2

Price Open 6.45

Volume: 11M

Avg Volume: 9.21M

Market Cap: 1.17B

P/E Ratio -37.53

52 Wk Range 1.74-6.99



GERN Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-08-31
178.62M
62.9M
9.73
35.21%

2018-08-15
178.62M
59.81M
16.10
33.48%

2018-07-31
178.62M
58.32M
15.66
32.65%

2018-07-13
168.08M
56.53M
10.41
33.63%




GERN Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-07-31
Q2 2018
AMC
-0.04 (1)
-0.04
0.00

2018-05-10
Q1 2018
N/A
0.00 (0)
-0.04
0.00

2018-05-08
Q1 2018
N/A
-0.04 (1)
0.00
0.00

2018-03-16
Q4 2017
AMC
-0.04 (2)
-0.05
-0.01

News

Premarket Gainers as of 9:05 am (09/25/2018) (2018-09-25 09:19 SeekingAlpha)

JONE +47% . More news on: Jones Energy, Inc., Applied DNA Sciences, Inc., Clean Diesel Technologies, Inc., Stocks on the move, , Top stock market news, Read more …

 


Statistics

Shares Outstanding: 183.62M

Top 15 Institution Percent: 35.90

Price To Sales: 1139.29

Price To Book: 5.62

Revenue: 163000

Gross Profit: N/A

Cash: 96.90M

Debt: N/A

Return On Assets: -18.33

Return On Equity: -19.36

Profit Margin: N/A

Price History

Beta: 2.58

50-day Moving Avg: 4.50

200-day Moving Avg: 3.48

YTD Change: N/A

5-day Change: 12.93

1-month Change: 19.46

3-month Change: 76.64

6-month Change: 3.68

1-year Change: 176.79

Revenue Per Share: 0.00

Revenue Per Employee: 9056.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Geron Corporation

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.geron.com

Geron Corp is a biopharmaceutical company. It supports the clinical stage development of a telomerase inhibitor, imetelstat.